Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HP568Phase 21 trial
Hinova Pharmaceuticals Inc. · Breast Cancer
- HR19042Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Autoimmune Hepatitis
- HRS-1301Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia
- HRS-1738Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer
- HRS-3095Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria
- HRS-4029Phase 21 trial
Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke
- HRS-5632Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Lipoprotein Disorder
- HRS-6213Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Patients With Solid Tumors
- HRS-6719Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Advanced/Metastatic Solid Tumors
- HRS-6768Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors
- HRS-7085Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis
- HRS-717Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-7172Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-7450Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke
- HRS-8364Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor
- HRS-9308Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Solid Tumor
- HRS-9563Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension
- HRS-9821Phase 21 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · COPD
- HRS5580Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Prevention of Postoperative Nausea and Vomiting
- HRS9432Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Patients With Candidemia and/or Invasive Candidiasis
- HRS9950Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Chronic Hepatitis B
- HRX215Phase 21 trial
HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases
- HS-10365Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Nonsmall Cell Lung Cancer
- HS-10374Phase 21 trial
Hansoh BioMedical R&D Company · Psoriasis
- HS-10390Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Kidney Disease
- HS-10516Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma
- HS-10561Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria
- HS-10566Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer
- HS-20105Phase 21 trial
Hansoh BioMedical R&D Company · Advanced Solid Tumor
- HS-20110Phase 21 trial
Hansoh BioMedical R&D Company · CRC
- HS-20118Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis
- HSK39775Phase 21 trial
Xizang Haisco Pharmaceutical Co., Ltd · Advanced Solid Tumors
- HSK42360-NaPhase 21 trial
Haisco Pharmaceutical Group Co., Ltd. · Metastatic Colorectal Cancer (CRC)
- HSK50042Phase 21 trial
Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)
- HST-1011Phase 21 trial
HotSpot Therapeutics, Inc · Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer
- HT-4253Phase 21 trial
Halia Therapeutics, Inc. · Alzheimers Disease
- HTMC0658YD0293Phase 21 trial
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Chronic Sinusitis Without Nasal Polyps
- HuL001Phase 21 trial
HuniLife Biotechnology, Inc. · Multiple Myeloma Refractory
- HW091077Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Refractory Chronic Cough
- HW201877Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)
- HW211026Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Actinic Keratosis
- HX009Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma
- HX044Phase 21 trial
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Advanced Solid Tumor Malignancies
- HX111Phase 21 trial
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Solid Tumor and Lymphoma
- HX301Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Glioma
- HX9428Phase 21 trial
Fujian Haixi Pharmaceuticals Co., Ltd. · Wet Age-related Macular Degeneration (AMD)
- HXN6005Phase 21 trial
Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)
- HY-0102Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- HY05350Phase 21 trial
Sichuan Huiyu Pharmaceutical Co., Ltd · Advanced Solid Tumor
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.